Skip to main content
HRTX logo

HRTX · Heron Therapeutics, Inc. · Documents

Track HRTX — free
$0.27 +0.01 (+2.23%) Play latest call Q2 2026 earnings call transcript
Market Cap
$50.25M
Shares
190.27M
Volume · Nov 19 3.61M Avg daily vol (3M) 4.54M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Feb 27
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $144.29M ▲ 13.6% Net loss $13.58M Diluted EPS -$0.09
2024
Mar 12
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $127.04M ▲ 18.0% Net loss $110.56M Diluted EPS -$0.80
2023
Mar 29
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $107.67M ▲ 24.7% Net loss $182.02M Diluted EPS -$1.67
Showing 51–100 of 175 documents
Key facts CIK 818033 CUSIP 427746102 13F (30d) 157 filings 141 filers Visit website Investor relations